TIME REQUIRED FOR ELIMINATION OF NEISSERIA-GONORRHOEAE FROM THE UROGENITAL TRACT IN MEN WITH SYMPTOMATIC URETHRITIS - COMPARISON OF ORAL AND INTRAMUSCULAR SINGLE-DOSE THERAPY

被引:18
作者
HAIZLIP, J
ISBEY, SF
HAMILTON, HA
JERSE, AE
LEONE, PA
DAVIS, RH
COHEN, MS
机构
[1] UNIV N CAROLINA, DEPT MED, CHAPEL HILL, NC 27599 USA
[2] UNIV N CAROLINA, DEPT MICROBIOL & IMMUNOL, CHAPEL HILL, NC 27599 USA
关键词
D O I
10.1097/00007435-199505000-00002
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background and Objectives: The spread of sexually transmitted diseases (STDs), including gonorrhea, is affected by the duration of infection. Oral antibiotic therapy for gonococcal infection has been shown to be as effective as conventional intramuscular injection with ceftriaxone. Rapid cure would be expected to limit further spread of gonorrhea, However, the speed with which Neisseria gonorrhoeae is eliminated from the urogenital tract has not been evaluated. Goal of this Study: To determine the time required for elimination of Neisseria gonorrhoeae from the urine, mucosa, and semen in male subjects after treatment with ceftriaxone (250 mg intramuscularly), ciprofloxacin (500 mg by mouth, single dose) or cefixime (400 mg by mouth, single dose). Results: In 14 subjects, gonococci were eliminated from the urine within 4 hours of therapy and the mucosa within 24 hours after therapy, In 9 additional subjects, gonococci were eliminated from the semen by 24 hours after therapy. Conclusions: These results support the efficacy of single-dose oral therapy for gonorrhea and suggest that earlier follow-up for proof of cure in clinical trials of new antibiotics for gonorrhea may be acceptable, Rapid elimination of gonorrhea reduces the risk for continued transmission of the organism.
引用
收藏
页码:145 / 148
页数:4
相关论文
共 20 条
[1]  
ANDERSON R M, 1991
[2]  
[Anonymous], 1993, MMWR Recomm Rep, V42, P1
[3]   HIV AND SYPHILIS SEROPREVALENCE AMONG CLIENTS WITH SEXUALLY-TRANSMITTED DISEASES ATTENDING A WALK-IN CLINIC AT COOK-COUNTY-HOSPITAL [J].
ANSELL, DA ;
HU, TC ;
STRAUS, M ;
COHEN, M ;
SHERER, R .
SEXUALLY TRANSMITTED DISEASES, 1994, 21 (02) :93-96
[4]   HUMAN-EXPERIMENTATION WITH NEISSERIA-GONORRHOEAE - RATIONALE, METHODS, AND IMPLICATIONS FOR THE BIOLOGY OF INFECTION AND VACCINE DEVELOPMENT [J].
COHEN, MS ;
CANNON, JG ;
JERSE, AE ;
CHARNIGA, LM ;
ISBEY, SF ;
WHICKER, LG .
JOURNAL OF INFECTIOUS DISEASES, 1994, 169 (03) :532-537
[5]   INVITRO ANTI-MICROBIAL SUSCEPTIBILITY OF PENICILLINASE-PRODUCING AND INTRINSICALLY RESISTANT NEISSERIA-GONORRHOEAE STRAINS [J].
COHEN, MS ;
COONEY, MH ;
BLACKMAN, E ;
SPARLING, PF .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 24 (04) :597-599
[6]  
FENG WC, 1977, JAMA-J AM MED ASSOC, V237, P896
[7]   DECREASED SUSCEPTIBILITY OF NEISSERIA-GONORRHOEAE TO CIPROFLOXACIN [J].
GRANSDEN, WR ;
WARREN, CA ;
PHILLIPS, I ;
HODGES, M ;
BARLOW, D .
LANCET, 1990, 335 (8680) :51-51
[8]   PHARMACOKINETICS OF CEFIXIME (CL-284,635, FK-027) IN HEALTHY-SUBJECTS AND PATIENTS WITH RENAL-INSUFFICIENCY [J].
GUAY, DRP ;
MEATHERALL, RC ;
HARDING, GK ;
BROWN, GR .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 30 (03) :485-490
[9]   A COMPARISON OF SINGLE-DOSE CEFIXIME WITH CEFTRIAXONE AS TREATMENT FOR UNCOMPLICATED GONORRHEA [J].
HANDSFIELD, HH ;
MCCORMACK, WM ;
HOOK, EW ;
DOUGLAS, JM ;
COVINO, JM ;
VERDON, MS ;
REICHART, CA ;
EHRET, JM .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (19) :1337-1341
[10]   COMPARISON OF CIPROFLOXACIN AND CEFTRIAXONE AS SINGLE-DOSE THERAPY FOR UNCOMPLICATED GONORRHEA IN WOMEN [J].
HOOK, EW ;
JONES, RB ;
MARTIN, DH ;
BOLAN, GA ;
MROCZKOWSKI, TF ;
NEUMANN, TM ;
HAAG, JJ ;
ECHOLS, R .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (08) :1670-1673